{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Assessing Research Misconduct in Randomized Controlled Trials *6162*
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
Cognate Code 6162Learning Objectives
After completing this continuing education activity you will be able to:
- Discuss how compromised data integrity in randomized controlled trials (RCTs) affects patient care.
- Summarize methods that have been applied in detecting previous cases of misconduct.
- Propose potential solutions to identify and callout research misconduct.
- List ways to improve the mechanism that investigates data manipulation.
Disclosures
Financial Disclosure: Ben W. Mol reports consultancy for ObsEva and grants from Merck, Ferring, and Guerbet. The other authors did not report any potential conflicts of interest.
Price:
$25.00
Credits:
- ACOG 2.0 CME
The American College of Obstetricians and Gynecologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)
The American College of Obstetricians and Gynecologists designates this journal-based activity for a maximum of 2 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
College Cognate Credit(s)
The American College of Obstetricians and Gynecologists designates this journal-based activity for a maximum of 2 Category 1 College Cognate Credits. The College has a reciprocity agreement with the AMA that allows AMA PRA Category 1 Credits TM to be equivalent to College Cognate Credits.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Physician
Test Code: ONG0921
Published: August 13, 2021
Expires: 9/30/2024
Sources:
Obstetrics & Gynecology
Required Passing Score: 7/9 (77%)
Specialties:
OB/GYN
Topics:
Randomized Controlled Trial